JOURNAL OF PHARMACEUTICAL AND SCIENCES (JPS)
Journal of Pharmaceutical and Sciences (JPS) is committed to publishing quality scientific articles in accordance with the ethics of publication of scientific articles. Published articles are articles that have been reviewed by competent reviewers in their respective fields of expertise, as determined by the editorial board. The Journal of Pharmaceutical and Sciences (JPS) highly values the aspects of originality, relevance, ultimately, statistical examiners, and the contribution of authors in considering the feasibility of scientific articles. The Peer Review process is carried out in accordance with the standards we have written on the Peer Review Process page. In the review process, there are several possibilities that occur, including : the article will be accepted, minor revisions, major revisions, and articles rejected for publication. Scientific articles that reviewed for revision will be published have resubmitted the revised article, while articles that are rejected will not be reviewed. Authors are required to fill out the Copyright Transfer Agreement form and Non-Plagiarism Statement before the article is published. Articles not submitted or being published in other journals.
The following statement describes the ethical behavior of all parties involved in the publication of articles for the Journal of Pharmaceutical and Sciences (JPS), namely: authors, editors, and reviewers.
Authors, editors, reviewers have the following obligations:
A. Duties of Authors (This Rule Was Made Based on Elsevier's Policy Guidelines)
A.1. Reporting standards
Authors submitting original research articles must present an accurate calculation of the research carried out in accordance with the objectives and discussion of the significance of the results. The primary data must be represented in the manuscript. The manuscript should contain sufficient detail and references to allow others to replicate the research. Deliberately made reports of fraud or inaccurate statements are unethical and unacceptable behavior. Professional published reviews and articles must also be accurate and objective, and editors must be able to identify this clearly.
A.2. Data Access and Retention
During the publishing process, the Author may be asked to provide raw data relating to the article manuscript for the purposes of the editorial review process, and if possible, the Author must provide access to the public to such data, and must be prepared under any circumstances to save the data for a period of time. Reasonable after publication.
A.3. Originality and Plagiarism
The Author must be able to ensure that what has been written is entirely original work, and if the Author has used the work or words of others, it must be quoted appropriately. Plagiarism can take several forms, ranging from admitting other people's manuscripts to their works, copying or quoting substantial parts of other texts without attribution, and claiming the results of research done by others. Plagiarism in all its forms constitutes unethical behavior and is not acceptable for publication
A.4. Multiple, Redundant, and Simultaneous Publications
Authors should not publish manuscripts that describe the same basis for research in more than one journal. Submitting the same manuscript in more than one journal at the same time is unethical and unacceptable behavior. In general, authors should not submit manuscripts for consideration in other previously published journals. The publication of several types of articles (clinical guidelines, translations) in more than one journal can sometimes be justified on the condition that it meets certain conditions. The writer and editor of the journal concerned must approve secondary publications that must reflect the same data and interpretation of the primary documents. Primary references should be cited in secondary publications.
A.5. Source recognition
Proper acknowledgment of the work of others must always be written down. Authors should cite publications that have influenced the research reported. Information obtained privately, such as in conversations, correspondence, or discussions with third parties, may not be used or reported without written permission from the source. Information obtained in confidential service processes such as jury texts or grant applications may not be used without the written permission of the authors involved.
A.6. Writers in Manuscripts
Authors should be limited to those who have contributed significantly to the conception, implementation, or interpretation of the reported research. Everyone who has made a significant contribution should be a co-author. If there are other people who have participated in the substantive aspects of the research, they must be recognized or registered as contributors. The correspondence writer must ensure that all appropriate co-authors have been included in the manuscript and that all co-authors have seen and approved the final manuscript and agree to submit the manuscript for publication.
A.7. Hazards and Human or Animal Subjects
Authors who submit research articles in which the research involves chemicals, procedures, or equipment that have unusual dangers in their use, the authors must identify them in the manuscript. If the research involves the use of animals or human subjects, the Author must ensure that the text contains a statement regarding all procedures carried out in accordance with the law and guidelines from the relevant institution, and the institutional committee concerned has approved it. Authors must include a statement in the text that informed consent has been obtained for experiments with human subjects. The right to privacy of the human subject must always be considered.
A.8. Ethical Approval
We require each research article submitted to the Journal of Pharmaceutical and Sciences (JPS) to include a statement that the research conducted has obtained ethical approval or a statement that ethics approval is not required, including the name of the ethics committee or institutional review board, ethics approval number or ID, and a statement that respondents have provided informed consent before participating in the research conducted.
A.9. Conflict of Interest
Authors must declare in their text any financial or substantial conflicts that could affect the results or interpretation of the text. All financial support for the research should be disclosed. Potential conflicts of interest that should be disclosed include employment, consultancy, stock ownership, fees, paid expert testimony, patent applications, grants, or other funds. Potential conflicts of interest should be disclosed at the earliest possible stage.
A.10. Fundamental Errors in Published Works
When an author finds significant errors or inaccuracies in his published work, the Author is obliged to immediately notify the journal editor or publisher and cooperate with the editor to retract or correct the manuscript. If the editor or publisher collaborates with a third party who publishes the manuscript with significant errors, the Author is obliged to withdraw or correct the manuscript or provide evidence to the editor to correct the original manuscript.
B. Duties of Editors (These Rules Are Based on Elsevier's Policy Guidelines and COPEís Best Practice Guidelines for Editors)
B.1. Publication Decisions
The editor of the Journal of Pharmaceutical and Sciences (JPS) is responsible for deciding the publication of scientific articles that have been submitted. Researchers and readers are allowed and advised always to encourage these decisions as part of the validation process. Editors work under the policies of the journal's editorial board and are constrained by applicable legal requirements regarding copyright infringement, defamation, and plagiarism. Editors may confer with other editors or reviewers in making this decision.
B.2. Fair play
Editors are required to evaluate the article manuscript according to the intellectual content regardless of the Author's race, gender, sexual orientation, religion, ethnicity, nationality, or political philosophy.
Editors and editorial staff may not disclose any information regarding the submitted manuscript to anyone other than the respective authors, reviewers, potential reviewers, other editorial advisors, and appropriate publishers.
B.4. Conflict of Interest
Materials that are not published in the submitted article manuscript may not be used for the editor's own research without the written consent of the author. Information or extraordinary ideas obtained from the review process must be kept confidential and not used for the editors' personal gain.
Editors must resign (ask co-editors, editorial associations or other members of the editorial board to review and consider) from a manuscript that has a conflict of interest as a result of a competitive, collaborative, or other relationship or connection with one of the authors, companies, or (possibly) institutions related to the article text.
The editor should require all contributors to disclose relevant competing interests and publish corrections if the competing interests are revealed after publication. If necessary, other appropriate actions should be taken, such as withdrawal of publication or expression of apology.
B.5. Involvement and Cooperation in Investigation
Editors should take reasonably responsive steps when complaints are found on ethics regarding the manuscripts of articles submitted in conjunction with the publisher or the public.
The steps that must be taken generally include: contacting the author of the script and giving consideration of each complaint or claim that has been made, conducting further communication to relevant agencies and research bodies and if the complaint has been enforced, then publication correction, withdrawal returns, expressions of apology, or other notes that may be relevant.
Any findings or actions that report unethical behavior in the publication should be considered even if it is discovered several years after publication.
B.6 Review of Manuscripts
The editor must ensure that every submitted article manuscript must initially be evaluated by the editor for its authenticity. Editors must organize and appoint peer reviews fairly and wisely. Editors must describe their peer review process in information for the authors and also indicate which sections of the journal were reviewed. Editors must designate appropriate peer reviews for articles under consideration for publication, selecting reviewers with sufficient expertise and avoiding reviewers who may have a conflict of interest.
C. Duties of Reviewer (This Rule is Made Based on Elsevier's Policy Guidelines and COPE's Best Practice Guidelines for Reviewers)
C.1. Contribution to Editorial Decisions
The review process helps editors in making editorial decisions and through the editorial communication with authors can also help writers improve their manuscripts. The review process is an essential component of formal communication and lies at the heart of the scientific method.
Reviewers who feel they do not have the qualifications to review the research reported on the manuscript or know that they are unlikely to do the review quickly should notify the editor and withdraw from the review process.
Any manuscripts that have been received for review must be treated as confidential documents. The manuscript may not be shown or discussed with others except with the permission of the editor.
C.4. Standard of Objectivity
Reviews must be conducted objectively. Reviewers must clearly demonstrate the results of their assessment, along with supporting arguments. Personal criticism of the author is not allowed
C.5. Source recognition
Reviewers should identify relevantly, published texts that were not cited by the authors. Any statements that include previously written observations, derivations, or arguments must be accompanied by relevant quotations. Reviewers should also communicate with the editor if there is a similarity in substance or overlap between the manuscript under consideration and any other manuscripts that have been published.
C.6. Conflict of Interest
Reviewers should not consider texts that have a conflict of interest as a result of competitive, collaborative, or other relationships with co-authors or the companies involved with the text.
Unpublished materials contained in the manuscript may not be used for the reviewer's own research without written permission from the Author. Information and extraordinary ideas obtained through the review process must be kept confidential and not used for personal gain.